SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one SK Biopharmaceuticals Co Ltd stock under the Base Case scenario is 33 908.03 KRW. Compared to the current market price of 104 000 KRW, SK Biopharmaceuticals Co Ltd is Overvalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
33 908.03 KRW
Overvaluation 67%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
10
Median 3Y
19.9
Median 5Y
21.8
Industry
2.6
Forward
15.4
vs History
3
vs Industry
Median 3Y
-71.7
Median 5Y
-70.9
Industry
23
Forward
111.8
vs History
vs Industry
Median 3Y
-63.4
Median 5Y
-57.4
Industry
17.8
vs History
vs Industry
Median 3Y
-83.9
Median 5Y
-77.6
Industry
25.4
vs History
18
vs Industry
2
Median 3Y
18.8
Median 5Y
20.5
Industry
2.2
vs History
64
vs Industry
10
Median 3Y
19.7
Median 5Y
21.4
Industry
2.8
Forward
15.1
vs History
66
vs Industry
10
Median 3Y
21.8
Median 5Y
23.9
Industry
5.4
vs History
12
vs Industry
0
Median 3Y
-46.2
Median 5Y
-50.7
Industry
13.7
Forward
82.7
vs History
7
vs Industry
Median 3Y
-45.5
Median 5Y
-53.7
Industry
17.2
Forward
99.7
vs History
vs Industry
Median 3Y
-60.4
Median 5Y
-55.5
Industry
16.5
vs History
vs Industry
Median 3Y
-56.8
Median 5Y
-52.8
Industry
19.3
vs History
51
vs Industry
8
Median 3Y
16
Median 5Y
17.1
Industry
2

Multiples Across Competitors

Competitors Multiples
SK Biopharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
SK Biopharmaceuticals Co Ltd
KRX:326030
8.1T KRW 17.5 241 138.3 197
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top